Loading...

  • risk
  • In particular, the excess risk of venous thromboembolism with combined oral contraceptives containing desogestrel or gestodene is 15 per 100000 users per year, not 15 per 100000 women. (bmj.com)
  • The committee's decision to advise doctors, pharmacists, and the public about the increased risk of thromboembolism with combined oral contraceptives containing desogestrel or gestodene was based on the results of three studies. (bmj.com)
  • The oral contraceptive pill is associated with death caused by venous thromboembolism (absolute risk increase with any combined oral contraception: 1 to 3 per million women per year). (aafp.org)
  • hospital
  • Emory Healthcare's Venous Thromboembolism Composite is the combined performance of Emory Johns Creek Hospital, Emory University Hospital, Emory University Hospital Midtown and Emory Saint Joseph's Hospital of Atlanta. (emoryhealthcare.org)
  • primary
  • Discovery of various thrombophilic factors, both primary and acquired, in the last 40 years has revolutionized prognostication and management of this potentially life-threatening condition due to its associated complication of pulmonary thromboembolism. (greenmedinfo.com)